John Kirk Email

VP Regulatory Affairs and Quality Assurance . MILLENDO THERAPEUTICS

Ann Arbor, MI

Location

k***@millendo.com

Primary Email

Current Roles

Employees:
6
Revenue:
$465k
About
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing's Syndrome (CS).
MILLENDO THERAPEUTICS Address
110 Miller Avenue
Ann Arbor, MI
United States
MILLENDO THERAPEUTICS Email

Past Companies

Millendo Therapeutics US, Inc.Vice President Regulatory Affairs and Quality Assurance
Amicus TherapeuticsVice President, Regulatory Affairs and Quality Assurance

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.